TriSalus Life Sciences Inc. (TLSI) — Tangible Net Worth Ratio
TriSalus Life Sciences Inc. (TLSI) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($6.55 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of TriSalus Life Sciences Inc. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
TriSalus Life Sciences Inc. Tangible Net Worth Ratio (2021–2021)
This chart shows how TriSalus Life Sciences Inc.'s Tangible Net Worth Ratio has changed across 1 annual periods from 2021 to 2021. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $6.55 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see TLSI stock market capitalisation.
Annual Tangible Net Worth Ratio for TriSalus Life Sciences Inc. (2021–2021)
The table below presents the year-by-year Tangible Net Worth Ratio for TriSalus Life Sciences Inc. from 2021 to 2021, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See financial agility of TriSalus Life Sciences Inc. to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 97.4% | $30.90 Million | $794.00K | $37.84 Million | — |